IMMUNOHISTOCHEMICAL STUDY OF MTOR+-FIBROBLASTS IN THE HUMAN SKIN DEVELOPMENT AND AGING DYNAMICS

The mammalian target of rapamycin (mTOR) pathway is an important cellular signaling pathway involved in a number of important physiological functions, including cell growth, proliferation, metabolism, protein synthesis and autophagy in response to various external stimuli. The mTOR signaling pathway significantly affects the aging process in the body, regulating cellular functions and adaptation to stressful conditions, but its significance for the development and physiological aging of human skin remains poorly understood and opens up prospects for further research. The aim of the study was to study the dynamics of changes in the proportion of mTOR⁺-fibroblasts in the human dermis during skin development and aging and to determine the possible role of mTOR in regulating the number and proliferative activity of fibroblasts during its age-related changes. The study material included 114 skin preparations from autopsy cases of different ages. The skin samples were autopsies of the lower part of the anterior neck surface obtained from fetuses starting from the 20^th week of pregnancy and from humans from birth to 85 years of age. MTOR⁺-, PCNA⁺- and vimentin⁺-fibroblasts were studied on formalin-fixed sections using the immunohistochemical method. The results obtained allow us to conclude that the skin of fetuses contains significantly more mTOR⁺-fibroblasts than the skin of humans from birth to 85 years of age. The proportion of fibroblasts expressing mTOR in the human dermis statistically significantly decreases from the age of 20 weeks to 60 years from 95% to 78%, which proves the importance of the age factor in the content of mTOR⁺-fibroblasts in the human dermis. In the postnatal period, a gradual decrease in the proportion of mTOR⁺-fibroblasts is observed. The negative dynamics of age-related changes in the proportion of mTOR⁺-fibroblasts in the dermis from the fetal period to 60 years of age is in the same direction as the age-related dynamics of the total number and proliferative activity of fibroblasts. Thus, evidence has been obtained for the age-specificity of mTOR participation in the regulation of fibroblast proliferation in the dermis of human skin.

1. Ali ES, Mitra K, Akter S, et al. Recent advances and limitations of mTOR inhibitors in the treatment of cancer. Cancer Cell Int. 2022;22(1):284. https://doi.org/10.1186/s12935-022-02706-8

2. Buddham R, Chauhan S, Narad P et al. Reconstruction and Exploratory Analysis of mTORC1 Signaling Pathway and Its Applications to Various Diseases Using Network-Based Approach. J Microbiol Biotechnol. 2022;32(3):365-377. https://doi.org/10.4014/jmb.2108.08007

3. Wu M, Cong Y, Wang K et al. Bisphenol A impairs macrophages through inhibiting autophagy via AMPK/mTOR signaling pathway and inducing apoptosis. Ecotoxicol Environ Saf. 2022;234:113395. https://doi.org/ 10.1016/j.ecoenv.2022.113395

4. Gunin AG, Petrov VV, Golubtzova NN et al. Age-related changes in angiogenesis in human dermis. Exp Gerontol. 2014;55:143-151. https://doi.org/10.1016/j.exger.2014.04.010

5. Holroyd AK, Michie AM. The role of mTOR-mediated signaling in the regulation of cellular migration. Immunol Lett. 2018;196:74-79. https://doi.org/10.1016/j.imlet.2018.01.015

6. Jung SH, Hwang HJ, Kang D et al. mTOR kinase leads to PTEN-loss-induced cellular senescence by phosphorylating p53. Oncogene. 2019;38(10):1639-1650. https://doi.org/10.1038/s41388-018-0521-8

7. Karagianni F, Pavlidis A, Malakou LS et al. Predominant Role of mTOR Signaling in Skin Diseases with Therapeutic Potential. Int J Mol Sci. 2022;23(3):1693. https://doi.org/10.3390/ijms23031693

8. Liu GY, Sabatini DM. mTOR at the nexus of nutrition, growth, ageing and disease. Nat Rev Mol Cell Biol. 2020r;21(4):183-203. https://doi.org/10.1038/s41580-019-0199-y

9. Liu P, Chen H, Yan L et al. Laminin α5 modulates fibroblast proliferation in epidural fibrosis through the PI3K/AKT/mTOR signaling path-way. Mol Med Rep. 2020;21(3):1491-1500. https://doi.org/10.3892/mmr.2020.10967

10. Qin D, Ren R, Jia C et al. Rapamycin Protects Skin Fibroblasts from Ultraviolet B-Induced Photoaging by Suppressing the Production of Reactive Oxygen Species. Cell Physiol Biochem. 2018;46(5):1849-1860. https://doi.org/10.1159/000489369

11. Panwar V, Singh A, Bhatt M et al. Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease. Signal Transduct Target Ther. 2023;8(1):375. https://doi.org/10.1038/s41392-023-01608-z

12. Walters HE, Cox LS. mTORC Inhibitors as Broad-Spectrum Therapeutics for Age-Related Diseases. Int J Mol Sci. 2018;19(8):2325. https://doi.org/10.3390/ijms19082325

13. Gunin AG, Golubtzova NN. Changes in the number of p23-positive fibroblasts in human dermis with aging. Adv Gerontol. 2021;34(5):694-700

14. Szwed A, Kim E, Jacinto E. Regulation and metabolic functions of mTORC1 and mTORC2. Physiol Rev. 2021;101(3):1371-1426. https://doi.org/10.1152/physrev.00026.2020

15. Zhang J, Yu H, Man MQ et al. Aging in the dermis: Fibroblast senescence and its significance. Aging Cell. 2024;23(2):e14054. https://doi.org/10.1111/acel.14054

16. Jiménez-Uribe AP, Gómez-Sierra T, Aparicio-Trejo OE et al. Backstage players of fibrosis: NOX4, mTOR, HDAC, and S1P; companions of TGF-β. Cell Signal. 2021;87:110123. https://doi.org/10.1016/j.cellsig.2021.110123

17. Qin Z, Xia W, Fisher GJ, et al. YAP/TAZ regulates TGF-β/Smad3 signaling by induction of Smad7 via AP-1 in human skin dermal fibro-blasts. Cell Commun Signal. 2018;16(1):18. https://doi.org/10.1186/s12964-018-0232-3

18. Chen Q, Zhang H, Yang Y et al. Metformin Attenuates UVA-Induced Skin Photoaging by Suppressing Mitophagy and the PI3K/AKT/mTOR Pathway. Int J Mol Sci. 2022;23(13):6960. https://doi.org/10.3390/ijms23136960

19. Wang M, Charareh P, Lei X et al. Autophagy: Multiple Mechanisms to Protect Skin from Ultraviolet Radiation-Driven Photoaging. Oxid Med Cell Longev. 2019;2019:8135985. https://doi.org/10.1155/2019/8135985

20. Lim GE, Park JE, Cho YH et al. Alpha-neoendorphin can reduce UVB-induced skin photoaging by activating cellular autophagy. Arch Bio-chem Biophys. 2020;689:108437. https://doi.org/10.1016/j.abb.2020.108437